Stockreport

AstraZeneca Imfinzi combination fails advanced lung cancer study [Reuters]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF AstraZeneca Imfinzi combination fails advanced lung cancer study - Reuters 3 Min Read (Reuters) - A combination of AstraZeneca’s lung cancer drug Imfinzi and an experime [Read more]